COLL

Collegium Pharmaceutical Inc.

Price

$22.07

return (12m)

-36.23%

p/e

14.95

p/bv

2.30

DIVIDEND YIELD

0.00%

COLL price

Collegium Pharmaceutical

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment COLL

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-8.76%

3 months

-42.03%

1 year

-36.23%

2 years

-44.67%

5 years

11.92%

10 years

24.97%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals COLL

Valuation

P/E

14.95

Sector 1.27

Industry 8.57

P/BV

2.30

Sector 1.88

Industry 3.63

P/Revenue (PSR)

0.89

Sector 1.56

Industry 3.09

EV/EBITDA

8.30

Sector -46.85

Industry -17.98

EV/EBIT

98.04

Sector -51.35

Industry -94.21

P/EBITDA

1.85

Sector -31.66

Industry 7.07

P/EBIT

4.65

Sector -43.19

Industry -32.11

P/Total Assets

0.34

Sector 0.87

Industry 1.32

P/Net Current Assets

-0.59

Sector -26.04

Industry -3.44

P/Working Capital

39.47

Sector -4.00

Industry 7.65

EPS

1.48

Sector -0.70

Industry -0.23

BVPS

9.61

Sector 4.48

Industry 8.61

Efficiency

Gross Margin

60.02%

Sector 49.44%

Industry 55.16%

EBITDA Margin

35.40%

Sector -282.02%

Industry -13.47%

EBIT Margin

3.00%

Sector -164.03%

Industry -25.89%

Operating Margin

19.48%

Sector -19.60%

Industry -5.67%

Net Profit Margins

5.93%

Sector -23.82%

Industry -7.67%

Asset Turnover

0.09

Sector 0.13

Industry 0.13

Profitability

ROE

15.36%

Sector -23.80%

Industry -24.00%

ROA

2.24%

Sector -24.22%

Industry -5.96%

ROIC

1.16%

Sector -587.47%

Industry -21.90%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

1.03

Sector 1.90

Industry 2.56

Net Debt / EBITDA

-1.83

Sector -23.34

Industry 9.41

Net Debt / EBIT

-21.62

Sector -11.26

Industry -2.82

Net Debt / Equity

-0.42

Sector -0.63

Industry -0.19

Gross Debt / Equity

0.00

Sector -0.73

Industry 0.42

Equity/Assets

0.15

Sector 0.46

Industry 0.50

Liabilities/Assets

0.85

Sector 0.50

Industry 0.53

Growth

5Y Revenue CAGR

23.89%

Sector -

Industry -

5Y Earnings CAGR

-7.70%

Sector -

Industry -

Fundamentals COLL

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Collegium Pharmaceutical ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$22.07

Fair Value

$17.89

Upside

-18.94%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
COLL Collegium Pharmaceutical Inc.	$22.07	-37.25%	0.00%	14.95	2.30	15.36%	5.93%
LLY Eli Lilly and Compay	$1,139.27	38.90%	0.59%	38.06	30.01	78.84%	33.53%
SNY Sanofi	$39.70	-17.07%	4.45%	3.72	0.69	18.43%	14.25%
GSK GlaxoSmithKline PLC	$46.95	7.91%	3.77%	14.44	4.08	28.24%	14.54%
CRMD CorMedix Inc.	$7.23	-34.62%	0.00%	3.03	1.23	40.62%	40.49%
AMPH Amphastar Pharmaceuticals Inc.	$25.11	-6.98%	0.00%	13.95	1.43	10.23%	10.76%
RDY Dr. Reddy's Laboratories Ltd.	$12.16	-13.79%	0.69%	27.58	2.49	9.03%	10.14%
ENLV Enlivex Therapeutics Ltd.	$0.40	-97.41%	0.00%	0.01	0.00	63.85%	0.00%
JNJ Johnson & Johnson	$255.81	40.61%	2.06%	29.27	7.25	24.76%	21.48%
ISRG Intuitive Surgical Inc.	$395.40	-9.73%	0.00%	44.62	7.65	17.15%	28.44%
NVS Novartis AG	$140.03	8.37%	2.22%	20.91	6.36	30.41%	23.29%
TMO Thermo Fisher Scientific Inc.	$652.02	23.39%	0.28%	34.69	4.59	13.22%	15.04%
ABT Abbott Laboratories	$96.56	-25.26%	2.53%	31.55	3.35	10.61%	11.65%
MDT Medtronic PLC	$86.94	-4.56%	3.30%	21.10	2.17	10.29%	13.93%
CVS CVS Health Corporation	$86.67	17.21%	3.09%	22.49	1.38	6.12%	1.18%
BSX Boston Scientific Corp.	$42.80	-55.35%	0.00%	17.31	2.55	14.73%	17.49%
TMDX TransMedics Group Inc.	$77.58	-32.47%	0.00%	17.68	5.18	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$520.16	-16.12%	0.00%	36.04	25.47	70.67%	25.03%
RMD ResMed Inc.	$220.18	-17.85%	1.12%	20.92	4.84	23.13%	26.94%
HCA HCA Healthcare Inc.	$428.58	1.07%	0.71%	13.82	-29.45	-213.15%	8.77%
COHR Coherent Inc.	$336.58	193.57%	0.00%	81.57	5.84	7.16%	11.31%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

COLL - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Collegium Pharmaceutical

Collegium Pharmaceutical Inc.

Average Investor10 user rating

4.0 (0 people)

United States

24 years

Founded: 2002

2015

Time since IPO - 11 years

234

Employees

Collegium Pharmaceutical Inc. (United States) is listed on the Nasdaq and has a market capitalization of $716.41 million, with shareholders equity totaling $311.91 million.

The company employs approximately 234 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Collegium Pharmaceutical Inc. reported $808.21 million in revenue, generating net income of $47.92 million.

Key financial metrics include a P/E ratio of 14.95, a price-to-book (P/B) ratio of 2.30, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker COLL.

Market cap

$716.41 million

Net worth

$311.91 million

$311,909,000.00

Assets

$2.14 billion

$2,135,790,000.00

Total Shares Outstanding

32.46 million

32,460,000

Average Daily Trading Volume

$827.24 Thousand

$827,243.20

Sector

Health

Industry

Pharmaceutical Products

COLL

COLL revenue and profits

Financial Results COLL

DRAG THE FRAME TO SEE MORE DATA

COLL cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$86.67 15,38% (12M)

P/E

22.49

3.09%

ROE

6.12%

P/BV

1.38

CI - Cigna

$267.68 --11,99% (12M)

P/E

10.33

2.31%

ROE

16.04%

P/BV

1.66

CNC - Centene

$62.50 61,49% (12M)

P/E

-6.05

0.00%

ROE

-22.53%

P/BV

1.36

HUM - Humana

$383.17 37,00% (12M)

P/E

35.89

0.93%

ROE

6.63%

P/BV

2.38

SNY - Sanofi

$39.70 --18,93% (12M)

P/E

3.72

4.45%

ROE

18.43%

P/BV

0.69

JNJ - Johnson & Johnson

$255.81 38,68% (12M)

P/E

29.27

2.06%

ROE

24.76%

P/BV

7.25

LLY - Eli Lilly

$1,139.27 36,51% (12M)

P/E

38.06

0.59%

ROE

78.84%

P/BV

30.01

HCA - HCA Healthcare

$428.58 0,25% (12M)

P/E

13.82

0.71%

ROE

-213.15%

P/BV

-29.45